FDA — authorised 7 November 2019
- Application: NDA212279
- Marketing authorisation holder: GISKIT
- Local brand name: EXEM FOAM KIT
- Indication: FOAM — INTRAUTERINE
- Status: approved
🇺🇸 Exem Foam Kit in United States
FDA authorised Exem Foam Kit on 7 November 2019
Marketing authorisation
Exem Foam Kit in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is Exem Foam Kit approved in United States?
Yes. FDA authorised it on 7 November 2019.
Who is the marketing authorisation holder for Exem Foam Kit in United States?
GISKIT holds the US marketing authorisation.